Global Chest Implants Market Size, Share, and COVID-19 Impact Analysis, By Material (Silicone and Saline), By End-User (Hospitals, Specialty Clinics, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Chest Implants Market Insights Forecasts to 2035

• The Market Size is Expected to Grow at a CAGR of around 8.4% from 2025 to 2035
• The Worldwide Chest Implants Market Size is Expected to hold a significant share by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights and Consulting, The Global Chest Implants Market Size is predicted to hold a significant share by 2035 with a compound annual growth rate (CAGR) of 8.4% from 2025 and 2035. The market for chest implants has a number of opportunities to grow due to surging innovation in implant materials, sophisticated surgical techniques, and technological integration.

Market Overview

The Global Chest Implants Market Size is the global industry for the design, manufacturing, and sale of implants used in both cosmetic and reconstructive breast surgery. Chest implants refer to the prosthetic medical devices surgically placed to enhance the size, shape, or contour of the chest. The implants are inserted via small incisions along the armpit crease and placed directly under the chest muscle. Innovation and market expansion are anticipated as a result of major players' growing R&D efforts and innovation. For instance, in September 2020, POLYTECH Health & Aesthetics GmbH, a global leader in breast aesthetics, announced the market introduction of an expanded B-Lite portfolio, the world’s first and only lightweight breast implants. The expanding capabilities for improving women’s health & wellness are driving a huge surge in the global chest implants market.    

Report Coverage

This research report categorizes the chest implants market size based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the chest implants market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the chest implants market. 

Driving Factors

The chest implants market size is driven by the influence of social media platforms for aesthetic surgery by promoting idealized and digitally enhanced images. For instance, specific findings revealed that 70% of young adult women and 60% of young adult men reported dissatisfaction with their bodies, which leads to increased surgical considerations. An increasing demand for cosmetic and reconstructive surgeries, along with the government support for offering breast reconstruction surgery, is promoting the chest implants market. Additionally, increasing R&D activities and clinical trial studies are contributing to promoting the chest implants market. For instance, in April 2025, BellaSeno GmbH, an ISO 13485-certified medtech company developing resorbable scaffolds using additive manufacturing technologies, announced that Prof. Anand Deva presented new clinical data on BellaSeno’s novel, 3D printed, resorbable breast scaffolds at The Aesthetic MEET 2025 conference.

Restraining Factors

The chest implants market is restricted by the increased procedure costs and risk of surgical complications such as infection or capsular contracture. Further, product recalls and regulatory scrutiny affect consumer confidence, ultimately hampering the market demand.

Market Segmentation

The chest implants market share is classified into material and end-user.   

• The silicone segment dominated the market with a major share of over 80% in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the material, the chest implants market size is divided into silicone and saline. Among these, the silicone segment dominated the market with a major share of over 80% in 2024 and is projected to grow at a substantial CAGR during the forecast period. Silicone implants are the most common choice of patients and surgeons owing to their various benefits, like being lightweight, having a natural look, firm grip, and flexibility. Women’s silicone implants are made of silicone gel, while men’s silicone implants are made of solid silicone, with zero silicone leakage. Further, ongoing innovations in silicone technology for enhancing implant safety, durability, and aesthetic results, along with the surging development of next-generation silicone implants, are responsible for driving segmental market growth.

• The hospitals segment accounted for the dominant market share of around 40-50% in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end-user, the chest implants market is divided into hospitals, specialty clinics, and others. Among these, the hospitals segment accounted for the dominant market share of around 40-50% in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Hospitals offer advanced technology, skilled medical professionals, and exceptional care. For instance, the Hospital Ruber Internacional in Madrid is one of Spain’s most reputable private medical facilities, known for its excellence in plastic and cosmetic surgery. An increasing need for aesthetic enhancements, reconstructive needs for post-mastectomy, and increased procedural availability across specialty hospitals are propelling the chest implants market.

Regional Segment Analysis of the Chest Implants Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the chest implants market over the predicted timeframe.

North America is anticipated to hold the largest share of over 35% of the chest implants market over the predicted timeframe. The market ecosystem in North America is strong, due to the presence of implant manufacturers, including Sientra, Natrelle Breast Implants, and Implantech, that offer a diverse range of advanced implants. The market for chest implants has been driven by the region's increased adoption of breast implants post-mastectomy and aesthetic surgeries, along with an increased disposable income. Due to their innovative chest implants products and partnerships with other industry players have played a significant role in propelling the market's expansion. For instance, in August 2024, CollPlant and Stratasys announced a pre-clinical study for regenerative commercial-sized breast implants. The United States is the dominating country in the North America chest implants market, accounting for nearly 79-85% share during the forecast period. This is due to the increasing adoption of advanced technologies for conducting implantation procedures, along with the rising prevalence of breast cancer. For instance, as per U.S. Cancer Statistics, 279,731 new breast cancers were reported in females in the United States in 2022, and 42,213 females in the United States died from breast cancer in 2023.   

Asia Pacific is expected to grow at a rapid CAGR of about 11.5% in the chest implants market during the forecast period. The Asia Pacific area has a thriving market for chest implants due to its rapidly ageing population and increasing prevalence of chronic illness, along with an increasing disposable income. Due to an increasing R&D investment and manufacturing for delivering high-quality orthopaedic solutions, including implants, there is an upsurge in the chest implants market. For performing a wide range of medical treatments, including chest implants, many hospitals and clinics in the region are accredited by international organizations like JCI (Joint Commission International) and ISO (International Organization for Standardization). China is dominating the Asia Pacific chest implants market, driven by the presence of a large population base and awareness of cosmetic procedures.  

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the chest implants market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Mentor Worldwide LLC (Johnson & Johnson)
• Allergan (AbbVie)
• Establishment Labs Holdings Inc.
• GC Aesthetics
• POLYTECH Health & Aesthetics GmbH
• Implantech
• Allied Biomedical
• Sientra Inc.
• Sebbin SAS
• HansBiomed Co., Ltd.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In March 2025, BD (Becton, Dickinson and Company), a leading global medical technology company, announced the first patient treated in an Investigational Device Exemption (IDE) clinical trial intended to advance BD's efforts to achieve Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the use of GalaFLEX LITE Scaffold in decreasing capsular contracture (CC) recurrence during breast revision surgery.

• In March 2025, Establishment Labs Holdings Inc., a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced a partnership with GRAMMY Award-winning hitmaker Meghan Trainor.

• In August 2024, CollPlant Biotechnologies and Startasys Ltd. announced the initiation of a pre-clinical study with 200cc commercial sized regenerative implants printed on a Stratasys Origin 3D printer. The collaboration between CollPlant and Stratasys is focused on the development of a bioprinting solution for CollPlant's breast implants, in addition to finding solutions to scale up the implant's fabrication process.   

• In October 2023, GC Aesthetics, a long-established brand in breast aesthetics, and Bimini Health Tech (“Bimini”), a pioneer in novel healthcare solutions, announced their groundbreaking Joint Venture partnership aimed at revolutionizing breast reconstruction worldwide.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the chest implants market based on the below-mentioned segments:  

Global Chest Implants Market, By Material

• Silicone
• Saline

Global Chest Implants Market, By End-User

• Hospitals
• Specialty Clinics
• Others

Global Chest Implants Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa